Bone densitometry developer CompuMed is planning an international marketing push for its OsteoGram bone-mass density system. With U.S. sales of OsteoGram affected by ultrasound and peripheral devices, as well as dual-energy x-ray absorptiometry (DEXA) equipment already on the market, CompuMed believes that the international sector represents the best opportunity for the system.
The Los Angeles-based vendor said that it is pursuing marketing opportunities in countries where medical facilities and physicians have standard x-ray equipment already in place, and are seeking a cost-effective means of determining bone mineral density as an indicator of fracture risk. The firm said it has already made progress in China, sponsoring a clinical trial and setting up a distributor network.
CompuMed expects Chinese authorities to grant approval for OsteoGram in March. The firm said it will continue to sell OsteoGram in the U.S.
By AuntMinnie.com staff writersFebruary 6, 2002
Related Reading
CompuMed results slide in Q3, August 17, 2000
Copyright © 2002 AuntMinnie.com
